{"@context":{"@vocab":"https://cir.nii.ac.jp/schema/1.0/","rdfs":"http://www.w3.org/2000/01/rdf-schema#","dc":"http://purl.org/dc/elements/1.1/","dcterms":"http://purl.org/dc/terms/","foaf":"http://xmlns.com/foaf/0.1/","prism":"http://prismstandard.org/namespaces/basic/2.0/","cinii":"http://ci.nii.ac.jp/ns/1.0/","datacite":"https://schema.datacite.org/meta/kernel-4/","ndl":"http://ndl.go.jp/dcndl/terms/","jpcoar":"https://github.com/JPCOAR/schema/blob/master/2.0/"},"@id":"https://cir.nii.ac.jp/crid/1380016870448596643.json","@type":"Researcher","foaf:Person":[{"foaf:name":[{"@value":"Arnold S Monto"}],"foaf:familyName":[{"@value":"Monto"}],"foaf:givenName":[{"@value":"Arnold S"}]}],"career":[{"institution":{"notation":[{"@value":"School of Public Health, University of Michigan, Ann Arbor, MI, USA"}]}}],"product":[{"@id":"https://cir.nii.ac.jp/crid/1360016870448596608","@type":"Article","productIdentifier":[{"@type":"DOI","@value":"10.1136/bmj-2021-069761"},{"@type":"URI","@value":"http://data.bmj.org/tdm/10.1136/bmj-2021-069761"},{"@type":"URI","@value":"https://syndication.highwire.org/content/doi/10.1136/bmj-2021-069761"}],"notation":[{"@value":"Clinical severity of, and effectiveness of mRNA vaccines against, covid-19 from omicron, delta, and alpha SARS-CoV-2 variants in the United States: prospective observational study"}],"relation":[{"type":"creator"}]}],"dataSourceIdentifier":[{"@type":"CROSSREF","@value":"10.1136/bmj-2021-069761_8qJl3uZ8evHTb8DUjbKC7mzdWhE"}]}